Blake Johnson

Blake Johnson, Ph.D., is a Senior Medical Affairs Specialist with over a decade of experience in translational oncology research, focusing on biomarker discovery and clinical application. Blake co-founded Navaux, contributing to the development of a circulating Hepsin antigen assay, and held key positions as a Medical Science Liaison at Genentech and Director & Clinical Scientist at Stage I Diagnostics, Inc. With extensive expertise in pre-clinical and clinical research, Blake is currently the Director of Medical Affairs in Urologic Oncology at Merck and continues their academic journey at Ouachita Baptist University. They possess a Ph.D. in Biomedical Sciences from The University of Texas MD Anderson Cancer Center UTHealth Graduate School and a Master's degree in Human Molecular Genetics from the University of Aberdeen.